JAMP GLICLAZIDE-MR
Identification of Jamp Gliclazide-Mr
| No description |
Google image searchProduct monograph
Active ingredient
gliclazide, 30 MG
DIN: 02429764
Dosage form(s): TABLET (EXTENDED-RELEASE)
Route(s) of administration: ORAL
Schedule: Prescription
Company: JAMP PHARMA CORPORATION
Date: 04-OCT-2024
ATC:
- A10 — DRUGS USED IN DIABETES (ATC, ATC/DDD, )
- A10B — BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS (ATC, ATC/DDD)
- A10BB — Sulfonamides, urea derivatives (ATC, ATC/DDD)
- A10BB09 — GLICLAZIDE (ATC/DDD)
Reference brand drug: Diamicron
